Novartis stock jumps after drugmaker raises full-year guidance, launches $15 billion buyback
July 18, 2023 at 11:49 AM EDT
Novartis raised its guidance and announced the buybacks as the Swiss drugmaker reported second-quarter earnings, which topped Wall Street's expectations.
